The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Mayo Clinic
Tizona Therapeutics, Inc
City of Hope Medical Center
Novartis
BicycleTx Limited
Nanobiotix
Rondo Therapeutics
Maastricht University Medical Center
Scancell Ltd
Merck Sharp & Dohme LLC
Xencor, Inc.
NuCana plc
Medicenna Therapeutics, Inc.
Sotio Biotech Inc.
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.
Eli Lilly and Company
Ikena Oncology
Atreca, Inc.
Corvus Pharmaceuticals, Inc.
Xencor, Inc.
Evelo Biosciences, Inc.
Silverback Therapeutics
Incyte Corporation
Incyte Corporation
MultiVir, Inc.